bluedoor data·H-1B Jobs API·bluedoor.sh ->

Home / Companies / Corbus Pharmaceuticals Inc / Trends

Corbus Pharmaceuticals Inc H-1B trends

Quarterly LCA aggregate trend points for Corbus Pharmaceuticals Inc. Each point carries filing counts, distinct employers, distinct role titles, SOC coverage, wage metrics, certification counts, and source IDs when returned.

Summary

H-1B LCA filings for Corbus Pharmaceuticals Inc span 2016 Q2 to 2022 Q3, peaking at 4 filings in 2019 Q2.

The most recent reported period (2022 Q3) shows 1 filings.

LCA filings are labor-condition applications certified by the U.S. Department of Labor, not active job postings or approved USCIS H-1B petitions.

PeriodLCA countRole titlesSOC codesAvg wage lowAvg prevailingCertifiedCertification rate
2016 Q2111$67,021$56,7221100.0%
2019 Q2433$83,675$77,6694100.0%
2020 Q1111$110,000$107,7861100.0%
2022 Q2211$95,450$81,2242100.0%
2022 Q3111$98,338$81,2241100.0%

Frequently asked questions

How have H-1B filings for Corbus Pharmaceuticals Inc changed over time?
H-1B LCA filings for Corbus Pharmaceuticals Inc span 2016 Q2 to 2022 Q3, peaking at 4 filings in 2019 Q2. The most recent reported period (2022 Q3) shows 1 filings. LCA filings are labor-condition applications certified by the U.S. Department of Labor, not active job postings or approved USCIS H-1B petitions.
Get this page with API

Rendered from the bluedoor H-1B Jobs API. Reproduce it:

GET https://api.bluedoor.sh/h1b-jobs/v1/trends?company=corbus+pharmaceuticals+inc&metric=lca_countJSON